AVE 20.0% 0.2¢ avecho biotechnology limited

Ann: Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial, page-51

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 427 Posts.
    lightbulb Created with Sketch. 32
    I had a listen to the teleconference. Ross Murdoch and Paul Gavin spoke well and with a positive spin that the patch works for transdermal penetration of Ocyc through the skin. It did work for pain relief for a sub group but not overall.

    So where does that leave us now? Maybe death by a thousand cuts until the POH money runs out and the shares reach .001
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(20.0%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $2 1.126K

Buyers (Bids)

No. Vol. Price($)
22 34751789 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40153304 27
View Market Depth
Last trade - 12.40pm 08/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.